Big Four

EY pulls out as BioPharma auditor due to conflict of interest

BioPharma revealed its board is now proposing that the company's previous auditor, PricewaterhouseCoopers (PwC), be appointed for one further year

BioPharma Credit has revealed that ‘Big Four’ firm EY has decided to withdraw from its proposed role as auditor at the firm after discovering a conflict of interest due to tax work carried out by its U.S. offices.

Show More
Back to top button